ArticleBMC health services research2025
Stem cell transplantation cost in Iran.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionStem cell transplantation (SCT) is a crucial treatment for various blood disorders and cancers. This procedure involves the transfer of healthy stem cells to replace damaged or diseased cells, restoring healthy blood cell production and alleviating symptoms. This study aimed to calculate the total cost of SCT at Shariati Hospital, Tehran, Iran.
methodA retrospective cross-sectional design was employed, analyzing data from 143 SCT patients admitted between August 2022 and March 2023. Activity-Based Costing (ABC) was utilized to allocate costs across combined operational centers, encompassing intermediate clinical support and patient care units. Cost data were extracted from hospital financial records and analyzed using SPSS and Excel in 2024.
resultsPatients had a mean age of 39 years and an average hospital stay of 27.2 days. The mean total cost per patient was 2,166,904,089 IRR (approximately $51,594 USD), equivalent to 24,232 international dollars based on Purchasing Power Parity (PPP) adjustment. Direct medical costs constituted 49% of total expenses, with overhead costs comprising 51%. Human resources accounted for the largest cost components, notably physicians (38.8%) and nursing staff (13.8%). Government subsidies covered 54.1% of direct costs, followed by out-of-pocket payments (13.9%) and basic insurance (12.8%).
conclusionStem cell transplantation imposes a substantial financial burden on the healthcare system in Iran. These findings underscore the urgent need for policy interventions to optimize resource allocation, establish standardized tariffs, and implement mechanisms that improve access and provide financial protection for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.